Ensure compliance with external submission standards. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in pharmaceutical regulatory affairs to exchange ideas on best practice and share case studies on innovation within the area.

Mapping the Data Universe: Big Data Presents Big Challenges for the Pharmaceutical Sector - Martin Bonney

Adopting a continual, pro-active approach to information governance is essential if pharmaceutical companies are to meet the challenges presented by big data. Full Article »

Events related to this topic:

Top 10 Trends that will Shape Pharma

Contributor: Pharma IQ
Posted: 8/22/2013

Top 10 Trends that will Shape Pharma - Pharma IQ

The global pharmaceutical industry has undergone some rapid changes in recent years, but what are the Top 10 Trends that will Shape Pharma. Pharma IQ investigate in this 3 minute video. Full Video »

Events related to this topic:

Ben Goldacre Makes the Case for Greater Transparency in Clinical Trials - Gerald Clarke

"Clinical trial information is being routinely and legally witheld and this needs to end." This is the assertion of Dr. Ben Goldacre; a doctor, science writer, campaigner on scientific issues including clinical trial transparency and author of the book Bad Pharma. Pharma IQ discussed the issue of clinical trial transparency with Dr. Goldacre, with a focus on how it will affect industry and why pharma companies have taken differing strategies in response to the campaign. Full Podcast »

Events related to this topic:

Ensuring Effective Translations - Initiate your Project

Contributor: Andrew Love
Posted: 5/7/2015

Ensuring Effective Translations - Initiate your Project - Andrew Love

As we continue in this series of articles expanding on Ensuring Effective Translations to help you establish your translation capability, the next set of tips are based around step 2 – Initiate your project. Full Column »

Events related to this topic:

Intellectual Property: Less Risk, More Reward

Pharma IQ partner IDBS looks at getting more from intellectual property, without compromising on security. Modern ways of working create previously unthinkable opportunities to make intellectual property (IP) work harder, but also throw up serious challenges around securing and protecting IP rights. In this paper, we’ll explore the drivers shaping the re-evaluation of IP in the research and development (R&D) sector and the technical features that make a platform like E-WorkBook a particularly suitable home for your organization’s IP assets. Full Whitepaper »

Events related to this topic:

Advertise With Us

Join the Pharmas IQ Community